Related Experiment Videos
Recessive mutations in a common pathway block thymocyte apoptosis induced by multiple signals
1Department of Molecular and Cellular Biology, University of Arizona, Tucson 85724.
The Journal of Cell Biology
|December 1, 1994
Summary
Researchers identified new early steps in programmed cell death (apoptosis) by studying glucocorticoid receptor (GR) resistant thymocyte mutants. These findings reveal multiple precommitment steps in apoptosis, crucial for understanding cell death pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- The glucocorticoid receptor (GR) is a transcription factor regulating genes essential for glucocorticoid-induced thymocyte apoptosis.
- Understanding the early molecular events in apoptosis is critical for various biological and disease processes.
Purpose of the Study:
- To genetically identify and characterize early steps in the apoptotic pathway using dexamethasone-resistant thymocyte mutants.
- To investigate the commonalities and precommitment steps shared by different apoptotic signaling pathways.
Main Methods:
- Isolation and characterization of glucocorticoid receptor-positive (GR+) dexamethasone-resistant mutants from the murine WEHI7.2 thymocyte cell line.
- Genetic analysis of apoptosis-defective (Apt-) mutants to identify genes involved in early apoptotic events.
- Assessing the effect of mutations on apoptosis induced by dexamethasone, gamma irradiation, and cyclic AMP (c-AMP).
Main Results:
- Identified multiple complementation groups with recessive, non-GR mutations blocking apoptosis.
- These mutations affect apoptosis induction prior to the protective action of Bcl-2.
- Demonstrated that diverse apoptotic stimuli (dexamethasone, gamma irradiation, c-AMP) converge on a common pathway.
Conclusions:
- Apoptosis induction involves multiple precommitment steps that can be disrupted by recessive mutations.
- Different signaling pathways converge on a shared apoptotic cascade, highlighting conserved mechanisms.
- The identified mutations provide insights into previously unknown early regulators of programmed cell death.